Pricing is a sensitive topic for the Life Sciences industry, but one thing is certain – the transparency by all stakeholders in the ecosystem makes the process of price setting and reference pricing across markets ever more important. To stay on top of the situation, a multitude of concurrent dimensional attributes require analysis. Such analysis is beyond the realm of possibility for human calculation, and even most standard databases being used. This article covers the latest in Gross-To-Net (G2N) thinking, and why this is a critical capability for any Life Sciences organization seeking success in the Asia-Pacific.

Connect with us